Evidence map›Paper›PMID 27039838›Full record

ArticleScientific reports2016

The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach.

Annalisa Dalzini, Christian Bergamini, Barbara Biondi, Marta De Zotti, Giacomo Panighel, Romana Fato, Cristina Peggion, Marco Bortolus, Anna Lisa Maniero

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Novel antimicrobial agents targeting theFrontiers in cellular and infection microbiology · 2022
    Review
  6. Article
  7. Article
  8. The Emericellipsins A-E from an Alkalophilic FungusJournal of fungi (Basel, Switzerland) · 2021
    Article
  9. Transcriptomic and Ultrastructural Analyses ofFrontiers in microbiology · 2021
    Article
  10. Targeted Amino Acid Substitutions in aInternational journal of molecular sciences · 2020
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Annalisa DalziniDipartimento di Chimica, Università di Padova, via Marzolo 1, 35131, Padova, Italy.
Christian BergaminiDipartimento di Farmacia e Biotecnologie, Università di Bologna, via Irnerio 48, 40126, Bologna, Italy.
Barbara BiondiDipartimento di Chimica, Università di Padova, via Marzolo 1, 35131, Padova, Italy.
Marta De ZottiDipartimento di Chimica, Università di Padova, via Marzolo 1, 35131, Padova, Italy.
Giacomo PanighelDipartimento di Chimica, Università di Padova, via Marzolo 1, 35131, Padova, Italy.
Romana FatoDipartimento di Farmacia e Biotecnologie, Università di Bologna, via Irnerio 48, 40126, Bologna, Italy.
Cristina PeggionDipartimento di Chimica, Università di Padova, via Marzolo 1, 35131, Padova, Italy.
Marco BortolusDipartimento di Chimica, Università di Padova, via Marzolo 1, 35131, Padova, Italy.
Anna Lisa ManieroDipartimento di Chimica, Università di Padova, via Marzolo 1, 35131, Padova, Italy.
University of Padua · ITUniversity of Bologna · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptaibols are peculiar peptides produced by fungi as weapons against other microorganisms. Previous studies showed that peptaibols are promising peptide-based drugs because they act against cell membranes rather than a specific target, thus lowering the possibility of the onset of multi-drug resistance, and they possess non-coded α-amino acid residues that confer proteolytic resistance. Trichogin GA IV (TG) is a short peptaibol displaying antimicrobial and cytotoxic activity. In the present work, we studied thirteen TG analogues, adopting a multidisciplinary approach. We showed that the cytotoxicity is tuneable by single amino-acids substitutions. Many analogues maintain the same level of non-selective cytotoxicity of TG and three analogues are completely non-toxic. Two promising lead compounds, characterized by the introduction of a positively charged unnatural amino-acid in the hydrophobic face of the helix, selectively kill T67 cancer cells without affecting healthy cells. To explain the determinants of the cytotoxicity, we investigated the structural parameters of the peptides, their cell-binding properties, cell localization, and dynamics in the membrane, as well as the cell membrane composition. We show that, while cytotoxicity is governed by the fine balance between the amphipathicity and hydrophobicity, the selectivity depends also on the expression of negatively charged phospholipids on the cell surface.

Indexed as

Cell Line, TumorCell ProliferationCell SurvivalDrug Screening Assays, AntitumorHeLa CellsHumansLipopeptidesPeptaibolsLipopeptidesPeptaibolstrichogin GA IV

Identifiers

PMID27039838
PMCPMC4819177
OpenAlexW2339437462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.